Skip to content

Diagnostic Imaging for Peripheral Arterial Disease: the DIPAD trial

Diagnostic Imaging for Peripheral Arterial Disease: the DIPAD trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN26717851
Enrollment
514
Registered
2005-12-20
Start date
2001-12-01
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Arterial Disease (PAD) Circulatory System Peripheral Arterial Disease (PAD)

Interventions

1. Magnetic resonance angiography: requires intravenous contrast material injection and duration of the examination is 30 minutes 2. Duplex ultrasound: requires no intravenous contrast

Sponsors

Erasmus Medical Centre (Netherlands)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Men and women at least 18 years old 2. Symptomatic Peripheral Arterial Disease (PAD) 3. An ankle-brachial index less than 0.90 4. Referred from the Department of Vascular Surgery for a diagnostic imaging workup to evaluate the feasibility of a revascularisation procedure

Exclusion criteria

Exclusion criteria: 1. Contraindications for MR angiography (e.g., pacemaker, cerebral vessel clipping, or claustrophobia) or CT angiography (e.g., severe renal insufficiency or adverse reactions to iodinated contrast agent) 2. Need an acute intervention at time of randomisation

Design outcomes

Primary

MeasureTime frame
Primary outcomes evaluated were quality of life and costs.

Secondary

MeasureTime frame
Secondary outcomes evaluated were clinical utility and functional patient outcomes.

Countries

Netherlands

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026